Warning letterFDA · Feb 5, 2019
Pure Nootropics, LLC MARCS-CMS 565425, February 05, 2019
Named company: Pure Nootropics, LLC
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, Alpha GPC, Lion’s Mane, CDP Choline Capsules,…
